相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bioenergetic deficits in Huntington's disease iPSC-derived neural cells and rescue with glycolytic metabolites
Amanda J. Kedaigle et al.
HUMAN MOLECULAR GENETICS (2020)
Energy Metabolism and Mitochondrial Superoxide Anion Production in Pre-symptomatic Striatal Neurons Derived from Human-Induced Pluripotent Stem Cells Expressing Mutant Huntingtin
James Hamilton et al.
MOLECULAR NEUROBIOLOGY (2020)
Mitochondrial fission in Huntington's disease mouse striatum disrupts ER-mitochondria contacts leading to disturbances in Ca2+ efflux and Reactive Oxygen Species (ROS) homeostasis
Marta Cherubini et al.
NEUROBIOLOGY OF DISEASE (2020)
Expression of mutant exon 1 huntingtin fragments in human neural stem cells and neurons causes inclusion formation and mitochondrial dysfunction
Rhia Ghosh et al.
FASEB JOURNAL (2020)
Drp1/Fis1-mediated mitochondrial fragmentation leads to lysosomal dysfunction in cardiac models of Huntington's disease
A. U. Joshi et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2019)
Targeting Huntingtin Expression in Patients with Huntington's Disease
Sarah J. Tabrizi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Precise Excision of the CAG Tract from the Huntingtin Gene by Cas9 Nickases
Magdalena Dabrowska et al.
FRONTIERS IN NEUROSCIENCE (2018)
Mitochondrial cristae remodelling is associated with disrupted OPA1 oligomerisation in the Huntington's disease R6/2 fragment model
Tanja Hering et al.
EXPERIMENTAL NEUROLOGY (2017)
CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington's Disease
Nivya Kolli et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington's disease
Su Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Histone Deacetylase Inhibitors Protect Against Pyruvate Dehydrogenase Dysfunction in Huntington's Disease
Luana Naia et al.
JOURNAL OF NEUROSCIENCE (2017)
Using CRISPR-Cas9 to Generate Gene-Corrected Autologous iPSCs for the Treatment of Inherited Retinal Degeneration
Erin R. Burnight et al.
MOLECULAR THERAPY (2017)
CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo
Alex Mas Monteys et al.
MOLECULAR THERAPY (2017)
Developmental alterations in Huntington's disease neural cells and pharmacological rescue in cells and mice
Ryan G. Lim et al.
NATURE NEUROSCIENCE (2017)
KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington's disease patients
Luisa Quinti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells
Xiaohong Xu et al.
STEM CELL REPORTS (2017)
Human iPSC-Derived Neural Progenitors Are an Effective Drug Discovery Model for Neurological mtDNA Disorders
Carmen Lorenz et al.
CELL STEM CELL (2017)
Permanent inactivation of Huntington's disease mutation by personalized allele-specific CRISPR/Cas9
Jun Wan Shin et al.
HUMAN MOLECULAR GENETICS (2016)
Manifestation of Huntington's disease pathology in human induced pluripotent stem cell-derived neurons
Evgeny D. Nekrasov et al.
MOLECULAR NEURODEGENERATION (2016)
Modeling autosomal dominant optic atrophy using induced pluripotent stem cells and identifying potential therapeutic targets
Jing Chen et al.
STEM CELL RESEARCH & THERAPY (2016)
Metabolic reprogramming during neuronal differentiation from aerobic glycolysis to neuronal oxidative phosphorylation
Xinde Zheng et al.
eLife (2016)
Fibroblasts of Machado Joseph Disease patients reveal autophagy impairment
Isabel Onofre et al.
SCIENTIFIC REPORTS (2016)
Cdk5-mediated mitochondrial fission: A key player in dopaminergic toxicity in Huntington's disease
Marta Cherubini et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Huntington disease iPSCs show early molecular changes in intracellular signaling, the expression of oxidative stress proteins and the p53 pathway
Wojciech J. Szlachcic et al.
DISEASE MODELS & MECHANISMS (2015)
HD iPSC-derived neural progenitors accumulate in culture and are susceptible to BDNF withdrawal due to glutamate toxicity
Virginia B. Mattis et al.
HUMAN MOLECULAR GENETICS (2015)
Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs
Donald G. Phinney et al.
NATURE COMMUNICATIONS (2015)
Three Huntington's Disease Specific Mutation-Carrying Human Embryonic Stem Cell Lines Have Stable Number of CAG Repeats upon In Vitro Differentiation into Cardiomyocytes
Laureen Jacquet et al.
PLOS ONE (2015)
Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington's disease knock-in striatal cells
Marcio Ribeiro et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Proteomics of Huntington's Disease-Affected Human Embryonic Stem Cells Reveals an Evolving Pathology Involving Mitochondrial Dysfunction and Metabolic Disturbances
Leon R. McQuade et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington's disease
Xiao-Hong Lu et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration
Xing Guo et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
The Effects of Nuclear Reprogramming on Mitochondrial DNA Replication
Richard D. W. Kelly et al.
STEM CELL REVIEWS AND REPORTS (2013)
Human Pluripotent Stem Cell Differentiation into Authentic Striatal Projection Neurons
Alessia Delli Carri et al.
STEM CELL REVIEWS AND REPORTS (2013)
Embryonic Stem Cells Neural Differentiation Qualifies the Role of Wnt/β-Catenin Signals in Human Telencephalic Specification and Regionalization
Camille Nicoleau et al.
STEM CELLS (2013)
Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient
Jung-Il Chae et al.
BIOCHEMICAL JOURNAL (2012)
Induced Pluripotent Stem Cells from Patients with Huntington's Disease Show CAG-Repeat-Expansion-Associated Phenotypes
CELL STEM CELL (2012)
Genetic Correction of Huntington's Disease Phenotypes in Induced Pluripotent Stem Cells
Mahru C. An et al.
CELL STEM CELL (2012)
Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease
Ulziibat P. Shirendeb et al.
HUMAN MOLECULAR GENETICS (2012)
The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity
Stefano Camnasio et al.
NEUROBIOLOGY OF DISEASE (2012)
UCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cells
Jin Zhang et al.
EMBO JOURNAL (2011)
Bioenergetic dysfunction in Huntington's disease human cybrids
I. Luisa Ferreira et al.
EXPERIMENTAL NEUROLOGY (2011)
Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage
Ulziibat Shirendeb et al.
HUMAN MOLECULAR GENETICS (2011)
A reduction in ATP demand and mitochondrial activity with neural differentiation of human embryonic stem cells
Matthew J. Birket et al.
JOURNAL OF CELL SCIENCE (2011)
Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity
Wenjun Song et al.
NATURE MEDICINE (2011)
Energy Metabolism in Human Pluripotent Stem Cells and Their Differentiated Counterparts
Sandra Varum et al.
PLOS ONE (2011)
Huntington's disease: a clinical review
Raymund A. C. Roos
ORPHANET JOURNAL OF RARE DISEASES (2010)
The Senescence-Related Mitochondrial/Oxidative Stress Pathway is Repressed in Human Induced Pluripotent Stem Cells
Alessandro Prigione et al.
STEM CELLS (2010)
Monitoring phosphorylation of the pyruvate dehydrogenase complex
Matthew J. Rardin et al.
ANALYTICAL BIOCHEMISTRY (2009)
Regulation of plasma membrane calcium fluxes by mitochondria
Nicolas Demaurex et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2009)
Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling
Stuart M. Chambers et al.
NATURE BIOTECHNOLOGY (2009)
Disease-specific induced pluripotent stem cells
In-Hyun Park et al.
CELL (2008)
Mechanisms of neurodegeneration in Huntington's disease
Joana M. Gil et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Mitochondrial DNA replication during differentiation of murine embryonic stem cells
Joao M. Facucho-Oliveira et al.
JOURNAL OF CELL SCIENCE (2007)
Mitochondrial-dependent Ca2+ handling in Huntington's disease striatal cells:: Effect of histone deacetylase inhibitors
Jorge M. A. Oliveira et al.
JOURNAL OF NEUROSCIENCE (2006)
Dynamic changes in mitochondrial biogenesis and antioxidant enzymes during the spontaneous differentiation of human embryonic stem cells
Young Min Cho et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Simultaneous monitoring of ionophore- and inhibitor-mediated plasma and mitochondrial membrane potential changes in cultured neurons
David G. Nicholls
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines
AV Panov et al.
NATURE NEUROSCIENCE (2002)
Site specificity of four pyruvate dehydrogenase kinase isoenzymes toward the three phosphorylation sites of human pyruvate dehydrogenase
LG Korotchkina et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
